Researchers identify the PKC-alpha enzyme as a promising therapeutic target in Alzheimer’s disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice.
Click here for original story, Enzyme drives cognitive decline in mice, provides new target for Alzheimer’s
Source: ScienceDaily